Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
NCT03992261
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
Halobetasol Topical Foam
Sponsor
Mayne Pharma International Pty Ltd